September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 12, 2025

Cemiplimab Reduces Recurrence in High-Risk cSCC

First adjuvant immunotherapy trial shows 23% absolute reduction in recurrence for resected cutaneous squamous cell carcinoma.

Conexiant

September 12, 2025

AI-Powered Proteomics Sharpens ALS Diagnosis

Researchers identified a biomarker panel predicting amyotrophic lateral sclerosis onset

The Pathologist

September 11, 2025

The Brutality of the Investment Landscape

Michael Murray has spent decades advising on deal management and commercial strategy – and he has a lot of tips and advice for budding start-ups looking for investment.

The Medicine Maker

September 09, 2025

Merger Cure? Rural Hospitals Try Networks

Mobile magnetic resonance imaging units and rural hospital networks support independent hospitals in improving access to diagnostic imaging and patient care in underserved areas.

KFF Health News

September 08, 2025

FDA Expands Indications for Von Willebrand Disease

FDA expands Vonvendi to adult routine prophylaxis (types 1 and 2) and pediatric on-demand/perioperative use.

Conexiant

September 08, 2025

Vascular Aging in Chronic Kidney Disease: New Insights

Researchers report somatic progerin and clonal propagation capacity of vascular smooth muscle cells in diseased arteries

The Pathologist

September 08, 2025

Crystal Clear: Why Image Quality Matters

How achieving diagnostic-ready image quality during scanning transforms pathology workflows and unlocks the future of computational pathology with AI

The Pathologist

September 05, 2025

ASCP Evaluates Cancer Biomarker Navigator Role

New lab personnel role could help improve and standardize testing for precision medicine in oncology

The Pathologist